Retinal Blood Flow Velocity in Patients with Age-Related Macular Degeneration

Refernces

• Fine SL. Age-related macular degeneration 1969-2004: a 35-year personal perspective. Am J Ophthalmol 2005;139:405–420
   PubMed Web of Science ®Google Scholar
• Feigl B. Age-related maculopathy – linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 2009;28:63–86
   PubMed Web of Science ®Google Scholar
• Vanderkooi JM, Erecinska M, Silver IA. Oxygen in mammalian tissue: methods of measurement and affinities of various reactions. Am J Physiol 1991;260:C1131–C1150
   PubMedGoogle Scholar
• Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye (Lond) 1990;4:273–289
   PubMedGoogle Scholar
• Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999;155:421–428
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419–1431
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 2006;19:361–372
   PubMedGoogle Scholar
• Ciulla TA, Harris A, Chung HS, Danis RP, Kagemann L, McNulty L, et al. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol 1999;128:75–80
   PubMed Web of Science ®Google Scholar
• Feigl B, Brown B, Lovie-Kitchin J, Swann P. Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis. Eye 2007;21:689–696
   PubMed Web of Science ®Google Scholar
• Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 1998;39:385–390
   PubMed Web of Science ®Google Scholar
• Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 2005;46:1033–1038
   PubMed Web of Science ®Google Scholar
• Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, Frantal S, et al. Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 2010;51:4220–4225
   PubMed Web of Science ®Google Scholar
• Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:358–363
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A, Bird AC. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol 1999;117:1353–1358
   PubMedGoogle Scholar
• Ciulla TA, Harris A, Martin BJ. Ocular perfusion and age-related macular degeneration. Acta Ophthalmol Scand 2001;79:108–115
   PubMedGoogle Scholar
• McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:4982–4991
   PubMed Web of Science ®Google Scholar
• McLeod DS, Taomoto M, Otsuji T, Green WR, Sunness JS, Lutty GA. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 2002;43:1986–1993
   PubMed Web of Science ®Google Scholar
• Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1997;115:741–747
   PubMed Web of Science ®Google Scholar
• Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224–2232
   PubMed Web of Science ®Google Scholar
• Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128:700–710
   PubMed Web of Science ®Google Scholar
• Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33–41
   PubMed Web of Science ®Google Scholar
• Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996;103:871–877
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1993;100:406–414
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D, Wormald RP, Wright L, Wessing A, Bird AC. Macular disease in an elderly population. Ger J Ophthalmol 1992;1:12–15
   PubMedGoogle Scholar
• Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583–587
   PubMed Web of Science ®Google Scholar
• Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 1995;102:640–646
   PubMed Web of Science ®Google Scholar
• Sato E, Feke GT, Menke MN, Wallace McMeel J. Retinal haemodynamics in patients with age-related macular degeneration. Eye (Lond) 2006;20:697–702
   PubMed Web of Science ®Google Scholar
• Grinvald A, Lieke E, Frostig RD, Gilbert CD, Wiesel TN. Functional architecture of cortex revealed by optical imaging of intrinsic signals. Nature 1986;324:361–364
   PubMed Web of Science ®Google Scholar
• Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123:1570–1574
   PubMed Web of Science ®Google Scholar
• Feigl B. Age-related maculopathy in the light of ischaemia. Clin Exp Optom 2007;90:263–271
   PubMed Web of Science ®Google Scholar
• Grisanti S, Tatar O. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog Retin Eye Res 2008;27:372–390
   PubMed Web of Science ®Google Scholar
• Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, et al. Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study. Int Ophthalmol 2009;29:213–224
   PubMedGoogle Scholar
• Wilkinson-Berka JL. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des 2004;10:3331–3348
   PubMed Web of Science ®Google Scholar
• Bhutto IA, Baba T, Merges C, McLeod DS, Lutty GA. Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp Eye Res 2010;90:155–167
   PubMed Web of Science ®Google Scholar
• Beutelspacher SC, Serbecic N, Barash H, Burgansky-Eliash Z, Grinvald A, Jonas JB. Central serous chorioretinopathy shows reduced retinal flow circulation in retinal function imaging (RFI). Acta Ophthalmol 2011;89:e479--e482
   PubMed Web of Science ®Google Scholar
• Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143–1150
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996;114:1193–1196
   PubMedGoogle Scholar
• Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404–409
   PubMed Web of Science ®Google Scholar
• Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 2010;128:750–758
   PubMed Web of Science ®Google Scholar
• Klein R, Cruickshanks KJ, Myers CE, Sivakumaran TA, Iyengar SK, Meuer SM, et al. The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam Studies. Ophthalmology 2013;120:1012–1019
   PubMed Web of Science ®Google Scholar
• Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 1998;82:996–1002
   PubMed Web of Science ®Google Scholar
• Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 1999;6:125–143
   PubMedGoogle Scholar
• Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280–1287
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003;44:3771–3777
   PubMed Web of Science ®Google Scholar
• Sato E, Feke GT, Appelbaum EY, Menke MN, Trempe CL, McMeel JW. Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006;244:963–971
   PubMedGoogle Scholar
• Cheung N, Liao D, Islam FM, Klein R, Wang JJ, Wong TY. Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study. Br J Ophthalmol 2007;91:430–433
   PubMed Web of Science ®Google Scholar
• Medeiros NE, Curcio CA. Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:795–803
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Sakata K, Harino S, Nagaoka T, Mimura T, et al. Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 2009;93:630–633
   PubMed Web of Science ®Google Scholar
• Ohnishi Y, Fujisawa K, Ishibashi T, Kojima H. Capillary blood flow velocity measurements in cystoid macular edema with the scanning laser ophthalmoscope. Am J Ophthalmol 1994;117:24–29
   PubMedGoogle Scholar
• Bonnin P, Pournaras JA, Lazrak Z, Cohen SY, Legargasson JF, Gaudric A, et al. Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin®) in neovascular age-related macular degeneration. Acta Ophthalmol 2010;88:641–645
   PubMed Web of Science ®Google Scholar
• Toklu Y, Cakmak HB, Raza S, Anayol A, Asik E, Simsek S. Short-term effects of intravitreal bevacizumab (Avastin®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration. Acta Ophthalmol 2011;89:e41–45
   PubMedGoogle Scholar
• Fontaine O, Olivier S, Descovich D, Cordahi G, Vaucher E, Lesk MR. The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration. Invest Ophthalmol Vis Sci 2011;52:7400--7405
   PubMed Web of Science ®Google Scholar
• Micieli JA, Tsui E, Lam WC, Brent MH, Devenyi RG, Hudson C. Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration. Acta Ophthalmol 2012;90:e13–20
   PubMed Web of Science ®Google Scholar
• Wickremasinghe SS, Guymer RH, Wong TY, Kawasaki R, Wong W, Qureshi S. Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration. Clin Experiment Ophthalmol 2012;40:59--66
   PubMedGoogle Scholar
• Barak A, Burgansky-Eliash Z, Barash H, Nelson DA, Grinvald A, Loewenstein A. The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization. Eur J Ophthalmol 2012;22:423–430
   PubMed Web of Science ®Google Scholar
• Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A. Reduced retinal blood flow velocity in diabetic retinopathy. Retina 2010;30:765–773
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Takahashi A, Sato E, Izumi N, Hein TW, Kuo L, et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol 2006;124:665–670
   PubMedGoogle Scholar